Kerry CASEY
1Patents
0h-index
4Co-inventors
19Inventor score
Filing activity: Dec 22, 2023 → Dec 22, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12410254B2 | Treatment of cardiometabolic disease with inhibitors of type I interferon signalling | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.